Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4208
Gene Symbol: MEF2C
MEF2C
0.030 GeneticVariation phenotype BEFREE 5q14.3 deletions including the MEF2C gene have been identified to date using genomic arrays in patients with severe developmental delay or intellectual disability, stereotypic behavior, epilepsy, cerebral malformations and a facial gestalt not really distinctive though characterized by broad and/or high, bulging forehead, upslanting palpebral fissures, flat nasal root and bridge, small, upturned nose, hypotonic small mouth resulting in cupid bow/tented upper lip. 23402836 2013
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.020 GeneticVariation phenotype BEFREE 7p22.1 microdeletions involving ACTB associated with developmental delay, short stature, and microcephaly. 27633570 2016
Entrez Id: 23111
Gene Symbol: SPART
SPART
0.300 Biomarker phenotype GENOMICS_ENGLAND SPG20 mutation in three siblings with familial hereditary spastic paraplegia. 28679690 2017
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.030 GeneticVariation phenotype BEFREE Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include <i>DMD</i> or when larger deletions extend distally to include <i>IL1RAPL1</i> and <i>DMD.</i> 29361664 2018
Entrez Id: 3981
Gene Symbol: LIG4
LIG4
0.020 GeneticVariation phenotype BEFREE DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. 11779494 2001
Entrez Id: 1801
Gene Symbol: DPH1
DPH1
0.140 GeneticVariation phenotype BEFREE Ovca1 homozygous mutant mice die at birth with developmental delay and cell-autonomous proliferation defects. 15661533 2005
Entrez Id: 80207
Gene Symbol: OPA3
OPA3
0.010 GeneticVariation phenotype BEFREE OPA3 mutations (IVS1-1G>C) were identified in 2 patients with the classic phenotype of type III 3MGA, but not in the other 11 patients with differing non-Costeff phenotypes associated with developmental delay and neurological signs and symptoms as described. 15902555 2005
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.180 Biomarker phenotype BEFREE PTEN gene sequencing should be considered in any child with macrocephaly and autism or developmental delay. 17505203 2007
Entrez Id: 5727
Gene Symbol: PTCH1
PTCH1
0.010 GeneticVariation phenotype BEFREE PTCH1 duplication in a family with microcephaly and mild developmental delay. 18830227 2009
Entrez Id: 84698
Gene Symbol: CAPS2
CAPS2
0.010 Biomarker phenotype BEFREE CAPS2-deficient (CAPS2(-/-)) mice show reduced secretion of BDNF and NT-3; consequently, the cerebella of these mice exhibit developmental deficits, such as delayed development and increased cell death in GCs, fewer branched dendrites on Purkinje cells (PCs), and loss of the intercrural fissure. 19238500 2009
Entrez Id: 4692
Gene Symbol: NDN
NDN
0.020 Biomarker phenotype BEFREE NDN is one of several genes inactivated in Prader-Willi syndrome (PWS), a developmental disorder characterized by obesity, hypotonia, and developmental delay. 20665884 2010
Entrez Id: 4157
Gene Symbol: MC1R
MC1R
0.010 Biomarker phenotype BEFREE MC1R mutant females, and females overexpressing the endogenous MC1R antagonist, agouti signalling protein, had a reduced formalin-induced inflammatory pain response, and a delayed development of inflammation-induced hyperalgesia and allodynia. 20856883 2010
Entrez Id: 7048
Gene Symbol: TGFBR2
TGFBR2
0.010 GeneticVariation phenotype BEFREE TGFBR2 deletion in a 20-month-old female with developmental delay and microcephaly. 21567932 2011
Entrez Id: 6678
Gene Symbol: SPARC
SPARC
0.010 Biomarker phenotype BEFREE SPARC is required for the optimal and rapid differentiation of Th17 cells, accordingly we show delayed development of experimental autoimmune encephalomyelitis whose pathogenesis involves Th17. 21962567 2011
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.190 Biomarker phenotype BEFREE Methyl-CpG binding protein 2 gene (MECP2) testing is indicated for patients with numerous clinical presentations, including Rett syndrome (classic and atypical), unexplained neonatal encephalopathy, Angelman syndrome, nonspecific mental retardation, autism (females), and an X-linked family history of developmental delay. 22123427 2012
Entrez Id: 4128
Gene Symbol: MAOA
MAOA
0.010 GeneticVariation phenotype BEFREE MAOA/B deletion syndrome in male siblings with severe developmental delay and sudden loss of muscle tonus. 23414621 2014
Entrez Id: 6666
Gene Symbol: SOX12
SOX12
0.010 Biomarker phenotype BEFREE SOX12 and NRSN2 are candidate genes for 20p13 subtelomeric deletions associated with developmental delay. 24019301 2013
Entrez Id: 84720
Gene Symbol: PIGO
PIGO
0.010 GeneticVariation phenotype BEFREE PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels. 24417746 2014
Entrez Id: 79053
Gene Symbol: ALG8
ALG8
0.010 Biomarker phenotype BEFREE ALG8-CDG is a severe disorder characterized by dysmorphic features, failure to thrive, protein-losing enteropathy, neurologic and ophthalmologic problems, and developmental delay. 24555185 2014
Entrez Id: 23261
Gene Symbol: CAMTA1
CAMTA1
0.010 Biomarker phenotype BEFREE CAMTA1 should be added to the growing list of genes associated with ID/DD, especially when behavioral problems, cerebellar signs, and/or dysmorphism are also present. 24738973 2015
Entrez Id: 1282
Gene Symbol: COL4A1
COL4A1
0.320 GeneticVariation phenotype BEFREE COL4A1 mutations disrupt the integrity of vascular basement membranes, so predisposing to a broad spectrum of disorders including periventricular leucomalacia, haemorrhagic stroke, aneurysm formation, epilepsy and developmental delay. 24864020 2014
Entrez Id: 773
Gene Symbol: CACNA1A
CACNA1A
0.030 GeneticVariation phenotype BEFREE CACNA1A mutations should be evaluated in infants and young children with paroxysmal tonic upgaze especially if associated with developmental delay, cerebellar signs, and other types of paroxysmal event. 25596066 2015
Entrez Id: 23095
Gene Symbol: KIF1B
KIF1B
0.020 Biomarker phenotype BEFREE CMT2A should be considered in patients with both axonal sensory-motor neuropathy and developmental delay. 26307494 2015
Entrez Id: 9927
Gene Symbol: MFN2
MFN2
0.010 Biomarker phenotype BEFREE CMT2A should be considered in patients with both axonal sensory-motor neuropathy and developmental delay. 26307494 2015
Entrez Id: 8260
Gene Symbol: NAA10
NAA10
0.050 Biomarker phenotype BEFREE NAA10 has previously been associated with Ogden syndrome, Lenz microphthalmia syndrome and non-syndromic developmental delay. 26522270 2015